BioSpace News Archive

Metagenomi, a gene editing company, today announced that it will present findings from its novel gene editing programs at the 24th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT), which will be held virtually May 11–14, 2021.

Travere Therapeutics, Inc. announced that Eric Dube, Ph.D., chief executive officer, will present at the BofA Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 5:00 p.m. ET.

When the world was coming to grips with an emerging global pandemic a year ago, scientists at Texas Biomedical Research Institute sprang into action.

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company’s New Drug Application (NDA) for mobocertinib (TAK-788)

REGENXBIO Inc. (Nasdaq: RGNX) today announced that four oral and nine poster presentations will be presented at the American Society of Gene and Cell Therapy’s 24th Annual Meeting taking place from May 11 to 14, 2021, in virtual format.

Supernus Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases, announced that the Company expects to report business results for the first quarter of 2021 after the market closes on Wednesday, May 5, 2021.

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the U.S. Food and Drug Administration (FDA) Oncologic Drugs Advisory Committee (ODAC) voted 7 to 2 in favor of maintaining accelerated approval of Tecentriq ® (atezolizumab) in combination with chemotherapy (

National Supercomputing Centre (NSCC) Singapore advances R&D across biomedicine, genomics, diseases, climate and more with an 8X faster system powered by the HPE Cray EX supercomputer